Treating Schizophrenia with Psychodynamic therapy among Elderly Patients

Abstract

The shifting demographics and inadequate treatment of schizophrenic seniors are creating a worldwide health issue. Soon, those aged 55 and over will make up a quarter or more of the global population of people diagnosed with schizophrenia. Schizophrenia is the third leading cause of disability-adjusted life-years among those 60 and older who suffer from mental and substance-use disorders.It is projected that older persons with schizophrenia have a bigger influence on health care expenses than the majority of other medical and mental diseases, with higher costs per patient as a result. Schizophrenia is a severe mental illness characterised by distorted perceptions of reality. Disabling hallucinations, delusions, and severely disorganised thought and behaviour are all possible symptoms of schizophrenia.